Photo of Dr. Keith A. Rodvold

Keith A. Rodvold


Interim Department Head, Professor, Pharmacy Practice

Contact

Building & Room:

105

Address:

833 South Wood Street, Chicago, IL, 60612

Office Phone:

(312) 996-3341

Office Phone TTY:

(312) 413-1797

Email:

kar@uic.edu

CV Link:

Keith A. Rodvold

About

Dr. Rodvold's areas of interest and research include pharmacokinetics/pharmacodynamics, infectious diseases and hematology.

Selected Publications

  • Justo JA, Mayer SM, Pai MP, Danziger LH, Novak RM, Rodvold KA. Pharmacokinetics of Ceftaroline in Normal Body Weight and Obese (Classes I, II, and III) Healthy Adult Subjects.. Antimicrobial agents and chemotherapy. 2015;. doi:10.1128/AAC.00498-15.

  • Rodvold KA, Danziger LH. (2015). Editorial commentary: improving prescribers to advance antimicrobial stewardship.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. Vol. 60. Issue 8. Page(s) 1259-61.

  • Merker AH, Danziger LA, Rodvold KC, Glowacki R. Pharmacokinetic and pharmacodynamic evaluation of ceftaroline fosamil.. Expert opinion on drug metabolism & toxicology. 2014;10(12):1741-50. doi:10.1517/17425255.2014.972932.

  • , Liao S, Clark D, Worboys P, Barriere SL, Rodvold KA. Variability in telavancin cross-reactivity among vancomycin immunoassays.. Antimicrobial agents and chemotherapy. 2014;58(12):7093-7. doi:10.1128/AAC.03785-14.

  • Pai MP, Neely M, Rodvold KA, Lodise TP. Innovative approaches to optimizing the delivery of vancomycin in individual patients.. Advanced drug delivery reviews. 2014;77:50-7. doi:10.1016/j.addr.2014.05.016.

  • Chambers HF, Bartlett JG, Bonomo RA, Chiou C, Cosgrove SE, Cross HR, Daum RS, Downing M, Evans SR, Knisely J, Kreiswirth BN, Lautenbach E, Mickley BS, Patel R, Pettigrew MM, Rodvold KA, Spellberg B, Fowler VG, Jr . Antibacterial resistance leadership group: open for business.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2014;58(11):1571-6. doi:10.1093/cid/ciu132.

  • Fischer JH, Sarto GE, Hardman J, Endres L, Jenkins TM, Kilpatrick SJ, Jeong H, Geller S, Deyo KL, Fischer PA, Rodvold KA. Influence of gestational age and body weight on the pharmacokinetics of labetalol in pregnancy.. Clinical pharmacokinetics. 2014;53(4):373-83. doi:10.1007/s40262-013-0123-0.

  • Pai MP, Rodvold KA. Aminoglycoside dosing in patients by kidney function and area under the curve: the Sawchuk-Zaske dosing method revisited in the era of obesity.. Diagnostic microbiology and infectious disease. 2014;78(2):178-87. doi:10.1016/j.diagmicrobio.2013.10.011.

  • Neely MN, Youn G, Jones B, Jelliffe RW, Drusano GL, Rodvold KA, Lodise TP. Are vancomycin trough concentrations adequate for optimal dosing?. Antimicrobial agents and chemotherapy. 2014;58(1):309-16. doi:10.1128/AAC.01653-13.

  • Rodvold KA, . Methicillin-resistant Staphylococcus aureus therapy: past, present, and future.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2014;58 Suppl 1:S20-7. doi:10.1093/cid/cit614.

  • Naderer OJ, Rodvold KA, Jones LS, Zhu JZ, Bowen CL, , Dumont E. Penetration of GSK1322322 into epithelial lining fluid and alveolar macrophages as determined by bronchoalveolar lavage.. Antimicrobial agents and chemotherapy. 2014;58(1):419-23. doi:10.1128/AAC.01836-13.

  • , Bleasdale SC, Rodvold KA. The empirical combination of vancomycin and a β-lactam for Staphylococcal bacteremia.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2013;57(12):1760-5. doi:10.1093/cid/cit560.

  • Rybak MJ, Rotschafer JC, Rodvold KA. (2013). Vancomycin: over 50 years later and still a work in progress.. Pharmacotherapy. Vol. 33. Issue 12. Page(s) 1253-5.

  • Tenero D, Bowers G, Rodvold KA, Patel A, Kurtinecz M, Dumont E, Tomayko J, . Intrapulmonary pharmacokinetics of GSK2251052 in healthy volunteers.. Antimicrobial agents and chemotherapy. 2013;57(7):3334-9. doi:10.1128/AAC.02483-12.

  • George JM, Colton BJ, Rodvold KA. National survey on continuous and extended infusions of antibiotics.. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2012;69(21):1895-904. doi:10.2146/ajhp110562.

  • Rodvold KA, Gotfried MH, Still JG, Clark K, Fernandes P. Comparison of plasma, epithelial lining fluid, and alveolar macrophage concentrations of solithromycin (CEM-101) in healthy adult subjects.. Antimicrobial agents and chemotherapy. 2012;56(10):5076-81. doi:10.1128/AAC.00766-12.

  • Chandorkar G, Huntington JA, Gotfried MH, Rodvold KA, Umeh O. Intrapulmonary penetration of ceftolozane/tazobactam and piperacillin/tazobactam in healthy adult subjects.. The Journal of antimicrobial chemotherapy. 2012;67(10):2463-9. doi:10.1093/jac/dks246.

  • George JM, Towne TG, Rodvold KA. Prolonged infusions of β-lactam antibiotics: implication for antimicrobial stewardship.. Pharmacotherapy. 2012;32(8):707-21. doi:10.1002/j.1875-9114.2012.01157.x.

  • Teng CB, Rezai K, Itokazu GS, Xamplas RC, Glowacki RC, Rodvold KA, Weinstein RA, Schwartz DN. (2012). Continuation of high-dose vancomycin despite nephrotoxicity.. Antimicrobial agents and chemotherapy. Vol. 56. Issue 6. Page(s) 3470-1; author reply 3472.

  • Rodvold KA, Solomkin JS. Vancomycin for surgical prophylaxis?. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012;54(10):1474-9. doi:10.1093/cid/cis027.

  • Fischer JH, Sarto GE, Habibi M, Kilpatrick SJ, Tuomala RE, Shier JM, Wollett L, Fischer PA, Khorana KS, Rodvold KA. Influence of body weight, ethnicity, oral contraceptives, and pregnancy on the pharmacokinetics of azithromycin in women of childbearing age.. Antimicrobial agents and chemotherapy. 2012;56(2):715-24. doi:10.1128/AAC.00717-11.

  • Lodise TP, Drusano GL, Butterfield JM, Scoville J, Gotfried M, Rodvold KA. Penetration of vancomycin into epithelial lining fluid in healthy volunteers.. Antimicrobial agents and chemotherapy. 2011;55(12):5507-11. doi:10.1128/AAC.00712-11.

  • Rodvold KA, Yoo L, George JM. Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antifungal, antitubercular and miscellaneous anti-infective agents.. Clinical pharmacokinetics. 2011;50(11):689-704. doi:10.2165/11592900-000000000-00000.

  • Shelton MJ, Lovern M, Ng-Cashin J, Jones L, Gould E, Gauvin J, Rodvold KA. Zanamivir pharmacokinetics and pulmonary penetration into epithelial lining fluid following intravenous or oral inhaled administration to healthy adult subjects.. Antimicrobial agents and chemotherapy. 2011;55(11):5178-84. doi:10.1128/AAC.00703-11.

  • Rodvold KA, George JM, Yoo L. Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antibacterial agents.. Clinical pharmacokinetics. 2011;50(10):637-64. doi:10.2165/11594090-000000000-00000.

  • Patel N, Pai MP, Rodvold KA, Lomaestro B, Drusano GL, Lodise TP. Vancomycin: we can’t get there from here.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2011;52(8):969-74. doi:10.1093/cid/cir078.

  • Yang YV, McBride MA, Rodvold KM, Tverdek FT, Trese A, Hennenfent J, Schiff G, Schumock G. Hospital policies and practices on prevention and treatment of infections caused by methicillin-resistant Staphylococcus aureus.. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2010;67(12):1017-24. doi:10.2146/ajhp090563.

  • Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, O’Neill PJ, Chow AW, Dellinger EP, Eachempati SR, Gorbach S, Hilfiker M, May AK, Nathens AB, Sawyer RG, Bartlett JG. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America.. Surgical infections. 2010;11(1):79-109. doi:10.1089/sur.2009.9930.

  • Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, O’Neill PJ, Chow AW, Dellinger EP, Eachempati SR, Gorbach S, Hilfiker M, May AK, Nathens AB, Sawyer RG, Bartlett JG. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2010;50(2):133-64. doi:10.1086/649554.

  • Lodise TP, Patel N, Lomaestro BM, Rodvold KA, Drusano GL. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2009;49(4):507-14. doi:10.1086/600884.

  • Rodvold KA, Nicolau DP, Lodise TP, Khashab M, Noel GJ, Kahn JB, Gotfried M, Murray SA, Nicholson S, Laohavaleeson S, Tessier PR, Drusano GL. Identifying exposure targets for treatment of staphylococcal pneumonia with ceftobiprole.. Antimicrobial agents and chemotherapy. 2009;53(8):3294-301. doi:10.1128/AAC.00144-09.

  • Rodvold KA. Collaborative strategies for improving clinical resource utilization: how pharmacists can make a difference.. Journal of managed care pharmacy : JMCP. 2009;15(5 Suppl):S10-4.

  • Rodvold KA. (2009). Journal of Managed Care Pharmacy. START (Stewardship Tactics for Antimicrobial Resistance Trends). Introduction.. Journal of managed care pharmacy : JMCP. Vol. 15. Issue 2 Suppl. Page(s) S3-4.

  • Rodvold KA. START learning by sharing: FAQs.. Journal of managed care pharmacy : JMCP. 2009;15(2 Suppl):S24-6.

  • Joseph J, Rodvold KA. The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.. Expert opinion on pharmacotherapy. 2008;9(4):561-75. doi:10.1517/14656566.9.4.561.

  • Pai MP, Norenberg JP, Anderson T, Goade DW, Rodvold KA, Telepak RA, Mercier RC. Influence of morbid obesity on the single-dose pharmacokinetics of daptomycin.. Antimicrobial agents and chemotherapy. 2007;51(8):2741-7. doi:10.1128/AAC.00059-07.

  • Slover CM, Rodvold KA, Danziger LH. Tigecycline: a novel broad-spectrum antimicrobial.. The Annals of pharmacotherapy. 2007;41(6):965-72. doi:10.1345/aph.1H543.

  • Mitropoulos IF, Rotschafer JC, Rodvold KA. Adverse events associated with the use of oral cephalosporins/cephems.. Diagnostic microbiology and infectious disease. 2007;57(3 Suppl):67S-76S. doi:10.1016/j.diagmicrobio.2006.12.002.

  • Itokazu GS, Schwartz DN, Garey KW, Rodvold KA, Danziger LH, Weinstein RA. Pharmacists’ perceptions of the effectiveness of antimicrobial control programs.. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2006;63(24):2504-8. doi:10.2146/ajhp060131.

  • Rodvold KA, Gotfried MH, Cwik M, Korth-Bradley JM, Dukart G, Ellis-Grosse EJ. Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose.. The Journal of antimicrobial chemotherapy. 2006;58(6):1221-9. doi:10.1093/jac/dkl403.

  • Pai MP, Momary KM, Rodvold KA. Antibiotic drug interactions.. The Medical clinics of North America. 2006;90(6):1223-55. doi:10.1016/j.mcna.2006.06.008.

  • Sprandel KA, Drusano GL, Hecht DW, Rotschafer JC, Danziger LH, Rodvold KA. Population pharmacokinetic modeling and Monte Carlo simulation of varying doses of intravenous metronidazole.. Diagnostic microbiology and infectious disease. 2006;55(4):303-9. doi:10.1016/j.diagmicrobio.2006.06.013.

  • Slama TG, Amin A, Brunton SA, File TM, Jr G, Milkovich KA, Rodvold DF, Sahm J, Varon D, Weiland , Jr . A clinician’s guide to the appropriate and accurate use of antibiotics: the Council for Appropriate and Rational Antibiotic Therapy (CARAT) criteria.. The American journal of medicine. 2005;118 Suppl 7A:1S-6S. doi:10.1016/j.amjmed.2005.05.007.

  • Schriever CA, Fernández CA, Rodvold KH, Danziger L. Daptomycin: a novel cyclic lipopeptide antimicrobial.. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2005;62(11):1145-58.

  • Hermsen ED, Hovde LB, Sprandel KA, Rodvold KA, Rotschafer JC. Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.. Antimicrobial agents and chemotherapy. 2005;49(2):685-9. doi:10.1128/AAC.49.2.685-689.2005.

  • Sprandel KA, Styrczula DE, Deyo KL, Sibley C, Rodvold KA. Stability and compatibility of levofloxacin and metronidazole during simulated and actual Y-site administration.. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2005;62(1):88-92.

  • Lodise TP, Jr BA, Lomaestro KH, Rodvold LL, Danziger G, Drusano . Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo simulation.. Antimicrobial agents and chemotherapy. 2004;48(12):4718-24. doi:10.1128/AAC.48.12.4718-4724.2004.

  • Sprandel KA, Schriever CA, Quinn JP, Gotfried MH, Hackett SB, Graham MH, Danziger LA, Rodvold K. Pharmacokinetics and pharmacodynamics of intravenous levofloxacin at 750 milligrams and various doses of metronidazole in healthy adult subjects.. Antimicrobial agents and chemotherapy. 2004;48(12):4597-605. doi:10.1128/AAC.48.12.4597-4605.2004.

  • Fiscella RG, Lai WW, Buerk B, Khan M, Rodvold KA, Pulido JS, Labib S, Shapiro MJ, Blair NP. Aqueous and vitreous penetration of linezolid (Zyvox) after oral administration.. Ophthalmology. 2004;111(6):1191-5. doi:10.1016/j.ophtha.2003.09.042.

  • Pai MP, Schriever CA, Diaz-Linares M, Novak RM, Rodvold KA. Sex-related differences in the pharmacokinetics of once-daily saquinavir soft-gelatin capsules boosted with low-dose ritonavir in patients infected with human immunodeficiency virus type 1.. Pharmacotherapy. 2004;24(5):592-9.

  • Gustin DM, Rodvold KA, Sosman JA, Diwadkar-Navsariwala V, Stacewicz-Sapuntzakis M, Viana M, Crowell JA, Murray J, Tiller P, Bowen PE. Single-dose pharmacokinetic study of lycopene delivered in a well-defined food-based lycopene delivery system (tomato paste-oil mixture) in healthy adult male subjects.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2004;13(5):850-60.

  • Luer MS, Neill KK, Gurley BJ, Shannon ML, Killian AD, Rodvold KA. Fluctuations in vancomycin CNS tissue concentrations following intermittent and continuous infusions in the rat.. Neurological research. 2004;26(3):312-5. doi:10.1179/016164104225014012.

  • Gotfried MH, Jung RR, Messick CW, Rubinstein IA, Garey KH, Rodvold K, Danziger L. Effects of six-week clarithromycin therapy in corticosteroid-dependent asthma: A randomized, double-blind, placebo-controlled pilot study.. Current therapeutic research, clinical and experimental. 2004;65(1):1-12. doi:10.1016/S0011-393X(04)90000-8.

  • Diwadkar-Navsariwala V, Novotny JA, Gustin DM, Sosman JA, Rodvold KA, Crowell JA, Stacewicz-Sapuntzakis M, Bowen PE. A physiological pharmacokinetic model describing the disposition of lycopene in healthy men.. Journal of lipid research. 2003;44(10):1927-39. doi:10.1194/jlr.M300130-JLR200.

  • Korytko PJ, Rodvold KA, Crowell JA, Stacewicz-Sapuntzakis M, Diwadkar-Navsariwala V, Bowen PE, Schalch W, Levine BS. Pharmacokinetics and tissue distribution of orally administered lycopene in male dogs.. The Journal of nutrition. 2003;133(9):2788-92.

  • Gotfried MH, Danziger LH, Rodvold KA. Steady-state plasma and bronchopulmonary characteristics of clarithromycin extended-release tablets in normal healthy adult subjects.. The Journal of antimicrobial chemotherapy. 2003;52(3):450-6. doi:10.1093/jac/dkg355.

  • Rodvold KA, Danziger LH, Gotfried MH. Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults.. Antimicrobial agents and chemotherapy. 2003;47(8):2450-7.

  • Sprandel KA, Rodvold KA. Safety and tolerability of fluoroquinolones.. Clinical cornerstone. 2003;Suppl 3:S29-36.

  • Pai MP, Rodvold KA, Schreckenberger PC, Gonzales RD, Petrolatti JM, Quinn JP. Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2002;35(10):1269-72. doi:10.1086/344177.

  • Drusano GL, Preston SL, Gotfried MH, Danziger LH, Rodvold KA. Levofloxacin penetration into epithelial lining fluid as determined by population pharmacokinetic modeling and monte carlo simulation.. Antimicrobial agents and chemotherapy. 2002;46(2):586-9.

  • Kraus DM, Pai MP, Rodvold KA. Efficacy and tolerability of extended-interval aminoglycoside administration in pediatric patients.. Paediatric drugs. 2002;4(7):469-84.

  • Rodvold KA. Pharmacodynamics of antiinfective therapy: taking what we know to the patient’s bedside.. Pharmacotherapy. 2001;21(11 Pt 2):319S-330S.

  • Rodvold KA, . Pharmacokinetics and pharmacodynamics of fluoroquinolones.. Pharmacotherapy. 2001;21(10 Pt 2):233S-252S.

  • Garey KW, Tesoro EP, Muggia V, Pasquier O, Rodvold KA. Cerebrospinal fluid concentrations of quinupristin-dalfopristin in a patient with vancomycin-resistant Enterococcus faecium [correction of faecalis] ventriculitis.. Pharmacotherapy. 2001;21(6):748-50.

  • Gotfried MH, Danziger LH, Rodvold KA. Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects.. Chest. 2001;119(4):1114-22.

  • Bearden DT, Rodvold KA. Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics.. Clinical pharmacokinetics. 2000;38(5):415-26. doi:10.2165/00003088-200038050-00003.

  • Quinn JP, Rodvold KA. Antibiotic policies in neonatal intensive-care units.. Lancet. 2000;355(9208):946-7. doi:10.1016/S0140-6736(00)90009-6.

  • Chuck SK, Raber SR, Rodvold KA, Areff D. National survey of extended-interval aminoglycoside dosing.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2000;30(3):433-9. doi:10.1086/313692.

  • Messick CR, Rodvold KA, . Modified time-kill assay against multidrug-resistant Enterococcus faecium with novel antimicrobial combinations.. The Journal of antimicrobial chemotherapy. 1999;44(6):831-4.

  • Rodvold KA. Clinical pharmacokinetics of clarithromycin.. Clinical pharmacokinetics. 1999;37(5):385-98. doi:10.2165/00003088-199937050-00003.

  • Friedenberg WR, Spencer SK, Musser C, Hogan TF, Rodvold KA, Rushing DA, Mazza JJ, Tewksbury DA, Marx JJ. Multi-drug resistance in chronic lymphocytic leukemia.. Leukemia & lymphoma. 1999;34(1-2):171-8. doi:10.3109/10428199909083394.

  • Penzak SR, Gubbins PO, Rodvold KA, Hickerson SL. Therapeutic drug monitoring of vancomycin in a morbidly obese patient.. Therapeutic drug monitoring. 1998;20(3):261-5.

  • Messick CR, Mamdani MR, McNicholl IH, Danziger LA, Rodvold KE, Condon RP, Walker AE, Edmiston C, Jr . Pharmacoeconomic analysis of ampicillin-sulbactam versus cefoxitin in the treatment of intraabdominal infections.. Pharmacotherapy. 1998;18(1):175-83.

  • Rodvold KA, Danziger LH, Quinn JP. Single daily doses of aminoglycosides.. Lancet. 1997;350(9089):1412. doi:10.1016/S0140-6736(97)22046-5.

  • Occhipinti DJ, Schoonover LL, Rypins EB, Danziger LH, Rodvold KA. Pharmacokinetics and pharmacodynamics of two multiple-dose piperacillin-tazobactam regimens.. Antimicrobial agents and chemotherapy. 1997;41(11):2511-7.

  • Gentry CA, Rodvold KA, Novak RM, Hershow RC, Naderer OJ. Retrospective evaluation of therapies for Staphylococcus aureus endocarditis.. Pharmacotherapy. 1997;17(5):990-7.

  • Rodvold KA, Everett JA, Pryka RD, Kraus DM. Pharmacokinetics and administration regimens of vancomycin in neonates, infants and children.. Clinical pharmacokinetics. 1997;33(1):32-51. doi:10.2165/00003088-199733010-00004.

  • Rodvold KA, Gotfried MH, Danziger LH, Servi RJ. Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers.. Antimicrobial agents and chemotherapy. 1997;41(6):1399-402.

  • , Killian AD, Woodward JG, Rodvold KA. In-vitro activity of a new oral streptogramin, RPR 106972, alone and in combination with rifampicin or ciprofloxacin against Legionella spp.. The Journal of antimicrobial chemotherapy. 1997;39(5):651-3.

  • Kanyok TP, Killian AD, Rodvold KA, Danziger LH. Pharmacokinetics of intramuscularly administered aminosidine in healthy subjects.. Antimicrobial agents and chemotherapy. 1997;41(5):982-6.

  • Rodvold KA, Gentry CA, Plank GS, Kraus DM, Nickel E, Gross JR. Bayesian forecasting of serum vancomycin concentrations in neonates and infants.. Therapeutic drug monitoring. 1995;17(3):239-46.

  • Gentry CA, Rodvold KA. How important is therapeutic drug monitoring in the prediction and avoidance of adverse reactions?. Drug safety. 1995;12(6):359-63.

  • Schoonover LL, Occhipinti DJ, Rodvold KA, Danziger LH. Piperacillin/tazobactam: a new beta-lactam/beta-lactamase inhibitor combination.. The Annals of pharmacotherapy. 1995;29(5):501-14.

  • Schumock GT, Raber SR, Crawford SY, Naderer OJ, Rodvold KA. National survey of once-daily dosing of aminoglycoside antibiotics.. Pharmacotherapy. 1995;15(2):201-9.

  • Rushing DA, Raber SR, Rodvold KA, Piscitelli SC, Plank GS, Tewksbury DA. The effects of cyclosporine on the pharmacokinetics of doxorubicin in patients with small cell lung cancer.. Cancer. 1994;74(3):834-41.

  • Danziger LH, Piscitelli SC, Occhipinti DJ, Resnick DJ, Rodvold KA. Steady-state pharmacokinetics of cefoperazone and sulbactam in patients with acute appendicitis.. The Annals of pharmacotherapy. 1994;28(6):703-7.

  • Vance-Bryan K, Rotschafer JC, Gilliland SS, Rodvold KA, Fitzgerald CM, Guay DR. A comparative assessment of vancomycin-associated nephrotoxicity in the young versus the elderly hospitalized patient.. The Journal of antimicrobial chemotherapy. 1994;33(4):811-21.

  • Fish DN, Gotfried MH, Danziger LH, Rodvold KA. Penetration of clarithromycin into lung tissues from patients undergoing lung resection.. Antimicrobial agents and chemotherapy. 1994;38(4):876-8.

  • Rodvold KA, Rotschafer JC, Gilliland SS, Guay DR, Vance-Bryan K. Bayesian forecasting of serum vancomycin concentrations with non-steady-state sampling strategies.. Therapeutic drug monitoring. 1994;16(1):37-41.

  • Bertino JS, Jr KA, Rodvold CJ, Destache . Cost considerations in therapeutic drug monitoring of aminoglycosides.. Clinical pharmacokinetics. 1994;26(1):71-81. doi:10.2165/00003088-199426010-00006.

  • Gentry CA, Paloucek FP, Rodvold KA. Prediction of acetaminophen concentrations in overdose patients using a Bayesian pharmacokinetic model.. Journal of toxicology. Clinical toxicology. 1994;32(1):17-30.

  • Rodvold KA. Pharmacotherapy of infectious complications in patients with acquired immunodeficiency syndrome.. Pharmacotherapy. 1993;13(6):626.

  • Pryka RD, Rodvold KA, Ting W, Levitsky S, Frost RW, Lettieri JT. Effects of cardiopulmonary bypass surgery on intravenous ciprofloxacin disposition.. Antimicrobial agents and chemotherapy. 1993;37(10):2106-11.

  • Kraus DM, Dusik CM, Rodvold KA, Campbell MM, Kecskes SA. Bayesian forecasting of gentamicin pharmacokinetics in pediatric intensive care unit patients.. The Pediatric infectious disease journal. 1993;12(9):713-8.

  • Rodvold KA, Piscitelli SC. New oral macrolide and fluoroquinolone antibiotics: an overview of pharmacokinetics, interactions, and safety.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1993;17 Suppl 1:S192-9.

  • Rushing DA, Piscitelli SC, Rodvold KA, Tewksbury DA. The disposition of doxorubicin on repeated dosing.. Journal of clinical pharmacology. 1993;33(8):698-702.

  • Piscitelli SC, Rodvold KA, Rushing DA, Tewksbury DA. Pharmacokinetics and pharmacodynamics of doxorubicin in patients with small cell lung cancer.. Clinical pharmacology and therapeutics. 1993;53(5):555-61.

  • , Stile-Calligaro IL, Rodvold KA, Sullivan-Bolyai J, Del Nido P, Levitsky S. Pharmacokinetics of intravenous vancomycin in pediatric cardiopulmonary bypass surgery.. The Pediatric infectious disease journal. 1993;12(4):300-4.

  • Vance-Bryan K, Guay DR, Gilliland SS, Rodvold KA, Rotschafer JC. Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique.. Antimicrobial agents and chemotherapy. 1993;37(3):436-40.

  • Gentry CA, Rodvold KA, Bertino JS, Jr . Methods of minimising the cost of aminoglycoside therapy to hospitals.. PharmacoEconomics. 1993;3(3):228-43.

  • Rodvold KA, Gentry CA, Plank GS, Kraus DM, Nickel E, Gross JR. Prediction of gentamicin concentrations in neonates and infants using a Bayesian pharmacokinetic model.. Developmental pharmacology and therapeutics. 1993;20(3-4):211-9.

  • Wilkes LH, Danziger LA, Rodvold K. Phenobarbital pharmacokinetics in obesity. A case report.. Clinical pharmacokinetics. 1992;22(6):481-4. doi:10.2165/00003088-199222060-00006.

  • Fish DN, Rodvold KA. Fluoroquinolone treatment of Enterococcus infection.. The Annals of pharmacotherapy. 1992;26(4):498-500.

  • McDermott CA, Kowalczyk AL, Schnitzler ER, Mangurten HH, Rodvold KA, Metrick S. Pharmacokinetics of lorazepam in critically ill neonates with seizures.. The Journal of pediatrics. 1992;120(3):479-83.

  • Piscitelli SC, Danziger LH, Rodvold KA. Clarithromycin and azithromycin: new macrolide antibiotics.. Clinical pharmacy. 1992;11(2):137-52.

  • Erdman SM, Rodvold KA. Trimethoprim/sulfamethoxazole concentrations in pneumocystis carinii Pneumonia.. DICP : the annals of pharmacotherapy. 1991;25(9):941-2.

  • Rushing DA, Friedenberg WR, Baldauf MC, Broste S, Gehlsen JA, Kriesel DH, Koontz DP, Rodvold KA. High-dose carmustine and autologous bone marrow reinfusion in the treatment of refractory or relapsed small cell lung carcinoma.. Cancer. 1991;68(4):720-4.

  • Pryka RD, Rodvold KA, Erdman SM. An updated comparison of drug dosing methods. Part IV: Vancomycin.. Clinical pharmacokinetics. 1991;20(6):463-76. doi:10.2165/00003088-199120060-00003.

  • Erdman SM, Rodvold KA, Pryka RD. An updated comparison of drug dosing methods. Part III: Aminoglycoside antibiotics.. Clinical pharmacokinetics. 1991;20(5):374-88. doi:10.2165/00003088-199120050-00003.

  • Erdman SM, Rodvold KA, Pryka RD. An updated comparison of drug dosing methods. Part II: Theophylline.. Clinical pharmacokinetics. 1991;20(4):280-92. doi:10.2165/00003088-199120040-00003.

  • Pryka RD, Rodvold KA, Erdman SM. An updated comparison of drug dosing methods. Part I: Phenytoin.. Clinical pharmacokinetics. 1991;20(3):209-17. doi:10.2165/00003088-199120030-00003.

  • Shwed JA, Danziger LH, Rodvold KA. A comparative evaluation of the safety and efficacy of cefotetan and cefoxitin in surgical prophylaxis.. DICP : the annals of pharmacotherapy. 1991;25(1):10-3.

  • Rodvold KA, Pryka RD, Kuehl PG, Blum RA, Donahue P. Bayesian forecasting of serum gentamicin concentrations in intensive care patients.. Clinical pharmacokinetics. 1990;18(5):409-18.

  • Pryka RD, Novak RM, Wagner DK, Rodvold KA. Clinical pharmacokinetics of daptomycin.. DICP : the annals of pharmacotherapy. 1990;24(3):255-6.

  • Danziger LH, Furmaga KM, Rodvold KA, Bombeck CT, Fischer JH. Nizatidine suppression of basal gastric acid output: a comparison of two intravenous dosage regimens.. Journal of clinical pharmacology. 1989;29(10):946-52.

  • Zokufa HZ, Solem LD, Rodvold KA, Crossley KB, Fischer JH, Rotschafer JC. The influence of serum albumin and alpha 1-acid glycoprotein on vancomycin protein binding in patients with burn injuries.. The Journal of burn care & rehabilitation. 1989;10(5):425-8.

  • Sukhani R, Garcia CJ, Munhall RJ, Winnie AP, Rodvold KA. Lidocaine disposition following intravenous regional anesthesia with different tourniquet deflation technics.. Anesthesia and analgesia. 1989;68(5):633-7.

  • Rodvold KA, Pryka RD, Garrison M, Rotschafer JC. Evaluation of a two-compartment Bayesian forecasting program for predicting vancomycin concentrations.. Therapeutic drug monitoring. 1989;11(3):269-75.

  • Pryka RD, Rodvold KA, Garrison M, Rotschafer JC. Individualizing vancomycin dosage regimens: one- versus two-compartment Bayesian models.. Therapeutic drug monitoring. 1989;11(4):450-4.

  • Zokufa HZ, Rodvold KA, Blum RA, Riff LJ, Fischer JH, Crossley KB, Rotschafer JC. Simulation of vancomycin peak and trough concentrations using five dosing methods in 37 patients.. Pharmacotherapy. 1989;9(1):10-6.

  • Pryka RD, Rodvold KA, Rotschafer JC. Teicoplanin: an investigational glycopeptide antibiotic.. Clinical pharmacy. 1988;7(9):647-58.

  • Rodvold KA, Zokufa H, Rotschafer JC. Aminoglycoside pharmacokinetic monitoring: an integral part of patient care?. Clinical pharmacy. 1988;7(8):608-13.

  • Rodvold KA, Rushing DA, Tewksbury DA. Doxorubicin clearance in the obese.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1988;6(8):1321-7.

  • Raineri DL, Cwik MJ, Rodvold KA, Deyo KL, Scaros LP, Fischer JH. Stability of nizatidine in commonly used intravenous fluids and containers.. American journal of hospital pharmacy. 1988;45(7):1523-9.

  • Rodvold KA, Blum RA, Fischer JH, Zokufa HZ, Rotschafer JC, Crossley KB, Riff LJ. Vancomycin pharmacokinetics in patients with various degrees of renal function.. Antimicrobial agents and chemotherapy. 1988;32(6):848-52.

  • Klamerus KJ, Rodvold KA, Silverman NA, Levitsky S. Effect of cardiopulmonary bypass on vancomycin and netilmicin disposition.. Antimicrobial agents and chemotherapy. 1988;32(5):631-5.

  • Paloucek FP, Rodvold KA. Evaluation of theophylline overdoses and toxicities.. Annals of emergency medicine. 1988;17(2):135-44.

  • Rodvold KA. Therapeutic considerations for infections caused by Staphylococcus epidermidis.. Pharmacotherapy. 1988;8(6 Pt 2):14S-18S.

  • Rotschafer JC, Garrison MW, Rodvold KA. Therapeutic update on glycopeptide and lipopeptide antibiotics.. Pharmacotherapy. 1988;8(4):211-9.

  • Rodvold KA, Paloucek FP, Jung D, Gallastegui J. Interaction of steady-state procainamide with H2-receptor antagonists cimetidine and ranitidine.. Therapeutic drug monitoring. 1987;9(4):378-83.

  • Rodvold KA, Zokufa H, Rotschafer JC. Routine monitoring of serum vancomycin concentrations: can waiting be justified?. Clinical pharmacy. 1987;6(8):655-8.

  • Blum RA, Rodvold KA. Recognition and importance of Staphylococcus epidermidis infections.. Clinical pharmacy. 1987;6(6):464-75.

  • Rodvold KA, Blum RA. Predictive performance of Sawchuk-Zaske and Bayesian dosing methods for tobramycin.. Journal of clinical pharmacology. 1987;27(5):419-24.

  • Stile IL, Fort M, Wurzburger RJ, Rodvold KA, Spector S, Hiatt IM, Hegyi T. The pharmacokinetics of naloxone in the premature newborn.. Developmental pharmacology and therapeutics. 1987;10(6):454-9.

  • Rodvold KA, Paloucek FP, Zell M. Accuracy of 11 methods for predicting theophylline dose.. Clinical pharmacy. 1986;5(5):403-8.

  • Ramirez-Lassepas M, Cipolle RJ, Rodvold KA, Seifert RD, Strand L, Taddeini L, Cusulos M. Heparin-induced thrombocytopenia in patients with cerebrovascular ischemic disease.. Neurology. 1984;34(6):736-40.

  • Cipolle RJ, Rodvold KA, Seifert R, Clarens R, Ramirez-Lassepas M. Heparin-associated thrombocytopenia: a prospective evaluation of 211 patients.. Therapeutic drug monitoring. 1983;5(2):205-11.

    • Education

  • Research Fellowship in Clinical Pharmacokinetics and Pharmacology, Research Fellowship in Clinical Pharmacokinetics and Pharmacology, College of Pharmacy at St. Paul-Ramsey Medical Center, St. Paul, MN

  • PharmD, , University of Minnesota College of Pharmacy, Minneapolis, MN

  • BS, , University of Minnesota College of Pharmacy, Minneapolis, MN